{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is required for maintaining normal ΔΨm and mitochondrial morphology of cultured SN dopaminergic neurons and exerts its neuroprotective effect by inhibiting ROS formation. PARK6 mutations cause loss of PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as loss of PINK1 function leading to mitochondrial dysfunction and oxidative stress, directly linking it to PARK6 pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial morphology, ΔΨm measurements, ROS quantification, and rotenone-induced cell death assays were used to assess PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The assays (mitochondrial membrane potential, morphology, ROS, and cell death) are well-established in mitochondrial disease research and directly model PINK1's role in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "PINK1 knockout neurons (null control) and wild-type PINK1 overexpression (positive control) were used. Mutant variants (G309D, E417G, CΔ145) failed to rescue mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type vs. knockout) were included, but the paper does not explicitly state experimental replicates. However, the assays are broadly accepted in the field, satisfying Sub-step 3b.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Significantly increased ROS and cell death were observed in mutant variants compared to wild-type PINK1. No OddsPath calculation was reported.",
          "judgment": "No",
          "reasoning": "Statistical analyses (e.g., p-values) were not explicitly reported. Total benign/pathogenic controls tested are unclear but likely fewer than 11 variants.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested 3 mutant variants (G309D, E417G, CΔ145) but did not provide a comprehensive set of control variants.",
          "judgment": "10 or less",
          "reasoning": "Total variant controls tested are unspecified but likely limited to the 3 mutants and wild-type PINK1, totaling fewer than 11.",
          "next_step_or_outcome": "Functional evidence strength"
        }
      ],
      "final_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "E",
          "alt": "G",
          "position": "417"
        },
        "variant_string_id": "PINK1 E417G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is required for maintaining normal ΔΨm and mitochondrial morphology of cultured SN dopaminergic neurons and exerts its neuroprotective effect by inhibiting ROS formation. PARK6 mutations cause loss of PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is explicitly defined as loss of PINK1 function leading to mitochondrial dysfunction and oxidative stress."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial morphology, ΔΨm measurements, ROS quantification, and rotenone-induced cell death assays were used to assess PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The assays directly model PINK1's role in mitochondrial function and Parkinson's disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "PINK1 knockout neurons (null control) and wild-type PINK1 overexpression (positive control) were used. Mutant variants (G309D, E417G, CΔ145) failed to rescue mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Basic controls were included, and the assays are broadly accepted in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Significantly increased ROS and cell death were observed in mutant variants compared to wild-type PINK1. No OddsPath calculation was reported.",
          "judgment": "No",
          "reasoning": "Statistical analyses were not explicitly reported. Total variant controls tested are likely fewer than 11.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested 3 mutant variants (G309D, E417G, CΔ145) but did not provide a comprehensive set of control variants.",
          "judgment": "10 or less",
          "reasoning": "Total variant controls tested are unspecified but likely limited to the 3 mutants and wild-type PINK1.",
          "next_step_or_outcome": "Functional evidence strength"
        }
      ],
      "final_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "C",
          "alt": "Δ145",
          "position": "145"
        },
        "variant_string_id": "PINK1 CΔ145"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is required for maintaining normal ΔΨm and mitochondrial morphology of cultured SN dopaminergic neurons and exerts its neuroprotective effect by inhibiting ROS formation. PARK6 mutations cause loss of PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is explicitly defined as loss of PINK1 function leading to mitochondrial dysfunction and oxidative stress."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging of mitochondrial morphology, ΔΨm measurements, ROS quantification, and rotenone-induced cell death assays were used to assess PINK1 function.",
          "judgment": "Yes",
          "reasoning": "The assays directly model PINK1's role in mitochondrial function and Parkinson's disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "PINK1 knockout neurons (null control) and wild-type PINK1 overexpression (positive control) were used. Mutant variants (G309D, E417G, CΔ145) failed to rescue mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "Basic controls were included, and the assays are broadly accepted in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Significantly increased ROS and cell death were observed in mutant variants compared to wild-type PINK1. No OddsPath calculation was reported.",
          "judgment": "No",
          "reasoning": "Statistical analyses were not explicitly reported. Total variant controls tested are likely fewer than 11.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested 3 mutant variants (G309D, E417G, CΔ145) but did not provide a comprehensive set of control variants.",
          "judgment": "10 or less",
          "reasoning": "Total variant controls tested are unspecified but likely limited to the 3 mutants and wild-type PINK1.",
          "next_step_or_outcome": "Functional evidence strength"
        }
      ],
      "final_strength": "PS3_supporting"
    }
  ]
}